Category: Flu Vaccine

Page 38«..1020..37383940..5060..»

Town Of Wilmington Flu Vaccine Clinic Scheduled For This Week – Patch

November 6, 2023

Oct 31, 2023 9:28 am EST | Updated Oct 31, 2023 2:14 pm EST

WILMINGTON, MA The Wilmington Health Department will hold a flu vaccine clinic at Town Hall at 121 Glen Road from 3 to 6 p.m. on Wednesday, Nov. 1.

Appointments are available for residents 5 and up. Registration is required.

Subscribe

More information is available via the Town of Wilmington.

The Massachusetts Department of Public recommends annual influenza vaccination for everyone 6 months and older with any licensed, age-appropriate flu vaccine (IIV, RIV4, or LAIV4) with no preference expressed for any one vaccine over another.

For people 65 years and older, the department noted that three flu vaccines are preferentially recommended: Fluzone High-Dose Quadrivalent vaccine, Flublok Quadrivalent recombinant flu vaccine, and Fluad Quadrivalent adjuvanted flu vaccine.

More information is available via the Massachusetts Department of Public Health.

See the original post:

Town Of Wilmington Flu Vaccine Clinic Scheduled For This Week - Patch

Do Simultaneous Flu & COVID Shots Increase Your Stroke Risk … – The Healthy

November 6, 2023

A specific audience needs this information the mostand here's why the vast majority of Americans shouldn't be dissuaded.

Getting the flu and COVID shots on the same day is a great way to kill two birds with one stoneprotecting yourself and the people you come into contact with from these infections, all while maybe taking the following day to put your feet up and rest off any vaccine side effects.

If you heard about the recent Food and Drug Administration(FDA) report that raised concerns about a potential increased risk of stroke when COVID-19 and flu vaccines are both administered within a two-month period, a newer discovery stresses that its important to clarify what the findings actually indicate.

Earlier in 2023, through a Medicare monitoring system that was designed to spot vaccine-related issues, the FDA and Centers for Disease Control and Prevention (CDC) were alerted to a potential uptick in strokes among adults aged 65 and older who received both COVID and flu vaccines. However, this observed risk couldnt be consistently replicated in other monitoring systems, and several additional studies didnt show a similar risk.

A more detailed examination of the data revealed that the risk of stroke was only elevated when older adults received a specific COVID vaccine along with the high-dose or adjuvanted influenza vaccine, which are typically given exclusively to people over 65 or with compromised immune systems to enhance vaccine protection.

Its worth noting that the increased risk was considerably low, affecting about three individuals out of every 100,000 vaccinated. Also, this elevated risk was primarily seen in those aged 85 and older. The study pointed to the high-dose flu vaccine as the likely contributor to this connection, although the increase in stroke risk associated with it was minimal.

So, should older adults skip their COVID and flu vaccines due to this study? The answer is a resounding no. Cleveland Clinic cardiologist Steven Nissen, MD, told CNN the associated risk of stroke in seniors is trivial in comparison to the risk for people over 85 of dying from COVID.

The FDA emphasizes that it remains crucial for older adults to receive both the flu shot and COVID boosters, despite the findings of this study. In a statement, the FDA told ABC News that it was confident in the safety, effectiveness and quality of the COVID-19 vaccines that the agency has authorized and approved The review conducted in this preprint paper is part of our ongoing safety surveillance efforts, which utilize a variety of data sources. The CDC also told the network that current vaccination guidelines had not changed in light of the study.

Vaccination is also important because both COVID and the flu can independently increase the risk of stroke and other serious health issues. Research on COVID has consistently highlighted the risk it poses to the heart and cardiovascular system. As Dr. Michelle Olive, of of NIHs National Heart, Lung, and Blood Institute, stated in a National Institutes of Health (NIH) report: Since the early days of the pandemic, we have known that people who had COVID-19 have an increased risk for cardiovascular disease or stroke up to one year after infection.

The American Heart Association (AHA) also points out that inflammation, whether from the flu or COVID, can heighten the risk of stroke, even among younger people, which is why it recommends both vaccines.

Recognizing the signs of a stroke is crucial for saving lives. The AHA recommends using the acronym F.A.S.T to identify stroke symptoms and promptly call for emergency assistance:

F: For facial drooping or an unbalanced appearance, which can be a sign of stroke.

A: For arm weakness, particularly on one side. A person may be asked to raise both arms, and if theres an issue, stroke may be suspected.

S: For speech difficulties, as someone having a stroke might speak words that are disconnected or incoherent.

T: Stands for time, emphasizing the urgency of seeking help for a suspected stroke. As some medical professionals who specialize in stroke treatment say, Minutes matter. Every minute that passes in the face of possible stroke represents the danger of greater permanent damage to the brain. Its inarguably better to have a false alarm than to delay potentially life-saving action.

For more wellness updates,subscribe toThe Healthy @Readers Digestnewsletterandfollow The Healthy onFacebookandInstagram.Keep reading:

More:

Do Simultaneous Flu & COVID Shots Increase Your Stroke Risk ... - The Healthy

Flu Vaccination Rapidly Growing Market Globally | CSL, GSK, Viatris … – Argyle Report

November 6, 2023

[New York, November 2023] An insightful market analysis report focusing on the Flu Vaccination Market has just been released by StatsNData, serving as a valuable resource for both industry leaders and newcomers. This comprehensive report offers a detailed exploration of the global Flu Vaccination market and its subsegments, providing revenue forecasts and strategic insights that can drive business success in the coming years in pharma-healthcare Industry.

Get a sample report:https://www.statsndata.org/download-sample.php?id=14225

In addition to answering these critical questions, the report offers a forward-looking perspective, providing insights into the future trajectory of the Flu Vaccination market. It equips decision-makers with the knowledge needed to navigate the markets evolution during the forecasted period effectively.

Some of the major companies influencing this Flu Vaccination market include:

Sanofi CSL GSK Viatris AstraZeneca Hualan Bio Changchun Institute of Biological Sinovac BCHT Jiangsu GDK KM Biologics

This Flu Vaccination research report sheds light on the major market players who are thriving in the market. Track business strategy, financial status and upcoming products.

This report caters to a wide audience, from industry experts seeking insights into the dynamic Flu Vaccination market to newcomers looking for guidance. Customization options are available to ensure the reports relevance to your specific needs.

Flu Vaccination The regional scope of the market is mostly mentioned in the region-focused report.

North America South America Asia Pacific Middle East and Africa Europe

Dont miss our exclusive 20% discount on this report: https://www.statsndata.org/ask-for-discount.php?id=14225

Flu Vaccination Market Segmentation Analysis

The market is segmented on the basis of categories such as type, product, and end user. This segmentation makes it possible to provide an accurate description of the market.

Flu Vaccination Market segmentation : By Type

6 Months to 3 Years Above 3 Years

Flu Vaccination Market Segmentation: By Application

Trivalent Influenza Vaccine Quadrivalent Influenza Vaccine

Key Questions Addressed in this Report:

Conclusion

Embrace data-driven decision-making with our comprehensive Flu Vaccination market research report. Its your roadmap to navigate the ever-changing market landscape and position your business for success.

Table Of Content

Chapter 1 Flu Vaccination Market Overview

1.1 Product Overview and Scope of Flu Vaccination

1.2 Flu Vaccination Market Segmentation by Type

1.3 Flu Vaccination Market Segmentation by Application

1.4 Flu Vaccination Market Segmentation by Regions

1.5 Global Market Size (Value) of Flu Vaccination (2018-2029)

Chapter 2 Global Economic Impact on Flu Vaccination Industry

2.1 Global Macroeconomic Environment Analysis

2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Flu Vaccination Market Competition by Manufacturers

3.1 Global Flu Vaccination Production and Share by Manufacturers (2019 to 2023)

3.2 Global Flu Vaccination Revenue and Share by Manufacturers (2019 to 2023)

3.3 Global Flu Vaccination Average Price by Manufacturers (2019 to 2023)

3.4 Manufacturers Flu Vaccination Manufacturing Base Distribution, Production Area and Product Type

3.5 Flu Vaccination Market Competitive Situation and Trends

Chapter 4 Global Flu Vaccination Production, Revenue (Value) by Region (2018-2023)

4.1 Global Flu Vaccination Production by Region (2018-2023)

4.2 Global Flu Vaccination Production Market Share by Region (2018-2023)

4.3 Global Flu Vaccination Revenue (Value) and Market Share by Region (2018-2023)

4.4 Global Flu Vaccination Production, Revenue, Price and Gross Margin (2018-2023)

Continue

Customization Requests:https://www. statsndata.org/request-customization.php?id=14225

Contact Us

[emailprotected]

https://www.statsndata.org

View post:

Flu Vaccination Rapidly Growing Market Globally | CSL, GSK, Viatris ... - Argyle Report

8 Dead From Flu And RSV In CA As Cold And Flu Season Arrives Early – Patch

November 6, 2023

Nov 3, 2023 4:43 pm PST | Updated Nov 3, 2023 4:47 pm PST

CALIFORNIA California recorded its fifth influenza death of the fledgling flu season this week, but it's another virus raising alarms for health officials up and down the state.

Respiratory syncytial virus infections better known as RSV is unusually active for this time of year. Infections across the state are up and three RSV deaths have been recorded so far. Health officials expect cases to increase in the coming weeks.

Subscribe

Current RSV activity "is more similar to activity seen later in November and December, compared to seasons prior," a California Department of Public Health spokesperson told Patch. "RSV activity has been starting earlier than usual during the past three RSV seasons."

It's a worrisome post-pandemic trend that could portend another vicious cold and flu season particularly for the very young and very old, for whom RSV is most deadly.

The first vaccines licensed in the U.S. to protect against RSV were approved earlier this year. The immunizations are recommended for those 60 and older or pregnant. There is a more limited supply available for infants and toddlers, according to state health officials.

"As with all immunizations, CDPH encourages individuals to check with their healthcare provider to determine which are available for them and their families," CDPH said.

In the Meantime, flu cases across the state remain minimal or low, though deaths and infections have increased slowly but steadily in recent weeks.

Of the five flu deaths so far this season in California, four were people 65 or older. One person was between 50 and 64 years old, according to CDPH data released Friday.

The CDC recommends annual flu vaccines for everyone over the age of 6. It's best to get them in September or October, but if you haven't gotten a shot yet, you should still get one, the CDC said.

The makeup of the flu vaccine varies annually, which means some years' vaccines are more effective against the year's strains than others.

"There is evidence that this years flu vaccine will be a strong match for circulating strains," the Los Angeles County Department of Public Health said in a statement.

In the Southern Hemisphere where the winter flu season just ended the vaccine reduced the risk of flu-associated hospitalizations by 52 percent, according to the CDC. Health officials say that bodes well for the vaccine's effectiveness in the Northern Hemisphere.

And as flu and RSV cases pick up, the CDPH say COVID-19 cases have decreased in recent weeks. But especially because cases typically increase in the winter, officials are urging Californias to get an updated booster shot.

"We encourage Californians to boost their immunity now by getting vaccinated or boosted in preparation for a potential increase in winter cases like we saw last year. Immunization prevents serious illness, including hospitalization and death," CDPH said.

View post:

8 Dead From Flu And RSV In CA As Cold And Flu Season Arrives Early - Patch

Quick takes: US COVID steady but flu up a bit, more avian flu … – University of Minnesota Twin Cities

November 6, 2023

US workers ill with influenza or COVID-19 were less likely to work onsite than those with other acute respiratory infections (ARIs) after the pandemic than before, concludes a study led by Centers for Disease Control and Prevention (CDC) researchers.

For the study, published yesterday in Emerging Infectious Diseases, the researchers analyzed data from participants in the seven-state US Influenza Vaccine Effectiveness Network who had ARIs from 2018 to 2022.

Participants, who were aged 19 to 64 years, completed a follow-up survey 1 or 2 weeks after enrollment and were asked about their health and work. Network sites were located in Michigan, Pennsylvania, Texas, Washington, California, Wisconsin, and Tennessee.

During the pre-COVID flu seasons, 1,245 people had confirmed flu and 2,362 had other ARIs. During the pandemic, 114 people had flu, 1,888 had COVID-19, and 2,523 had other ARIs. Among those with any ARI, 82.6% with flu, 61.4% with COVID-19, and 49.6% with other ARIs reported having fever.

Of all participants, 14.0% had worked only remotely before illness, 18.5% had hybrid experience, and 67.5% had worked onsite only.

On the third day of illness, 18.5% of participants worked remotely during the pandemic, compared with 8.8% before. In prepandemic flu seasons, 64.4% of workers with flu and 40.3% of with other ARIs worked offsite. Amid the pandemic, 66.7% of employees with COVID-19 and 48.3% with other ARIs didn't go to work.

Hybrid and remote work policies might reduce workplace exposures and help control spread of respiratory viruses.

Relative to employees without hybrid work experience, those who worked remotely were significantly more likely to telework, an effect more pronounced amid COVID-19 than during prepandemic flu seasons. In contrast, workers who had worked only onsite were more likely to not work at all on their scheduled days.

Employees with COVID-19 or flu were less likely to go to work than people with other ARIs. Few people who tested positive for COVID-19 by the second or third day of symptoms worked onsite.

"Hybrid and remote work policies might reduce workplace exposures and help control spread of respiratory viruses," the authors wrote.

See the article here:

Quick takes: US COVID steady but flu up a bit, more avian flu ... - University of Minnesota Twin Cities

Health department announces Indiana’s first 2 flu-related deaths of the season – WLKY Louisville

November 3, 2023

Indiana has had its first two flu-related deaths of the season.The Indiana Department of Health made the announcement on Thursday, but did not give any information regarding the deaths, including age or location, citing privacy laws.Last flu season, 270 Hoosiers died after contracting influenza."Influenza can quickly become a serious, even life-threatening illness for some Hoosiers," State Health Commissioner Lindsay Weaver said. "While no two flu seasons are exactly alike, we always recommend getting an annual flu shot as soon as possible to provide the best protection against becoming seriously ill."Flu season typically runs from October through May.The Centers for Disease Control and Prevention recommends everyone aged 6 months and older get a flu vaccine. For other ways to help prevent the spread of flu, click here.

Indiana has had its first two flu-related deaths of the season.

The Indiana Department of Health made the announcement on Thursday, but did not give any information regarding the deaths, including age or location, citing privacy laws.

Last flu season, 270 Hoosiers died after contracting influenza.

"Influenza can quickly become a serious, even life-threatening illness for some Hoosiers," State Health Commissioner Lindsay Weaver said. "While no two flu seasons are exactly alike, we always recommend getting an annual flu shot as soon as possible to provide the best protection against becoming seriously ill."

Flu season typically runs from October through May.

The Centers for Disease Control and Prevention recommends everyone aged 6 months and older get a flu vaccine.

For other ways to help prevent the spread of flu, click here.

Read the original post:

Health department announces Indiana's first 2 flu-related deaths of the season - WLKY Louisville

Flu and Covid-19 Vaccine drive happening in Jefferson Parish – WDSU New Orleans

November 3, 2023

Flu and Covid-19 Vaccine drive happening in Jefferson Parish

Leaders are trying to make it easy for you to roll up your sleeve and get your vaccines.

Updated: 6:09 AM CDT Nov 3, 2023

Jefferson Parish and the Louisiana Department of Health will be hosting a flu and COVID-19 vaccine drive on Saturday, November 4, 2023 from 10 a.m. to 2 p.m. at Nicholson Playground (7101 11th St., Marrero, LA 70072).Moderna bivalent COVID-19 vaccines will be administered to anyone over the age of 6 months that does not have insurance or is underinsured. The flu vaccine will be available for anyone over the age of 6 months. There is no cost to receive the flu or COVID-19 vaccines, please bring health insurance card. For more information, please contact the Jefferson Parish Emergency Management Department at (504) 349-5360.

Jefferson Parish and the Louisiana Department of Health will be hosting a flu and COVID-19 vaccine drive on Saturday, November 4, 2023 from 10 a.m. to 2 p.m. at Nicholson Playground (7101 11th St., Marrero, LA 70072).

Moderna bivalent COVID-19 vaccines will be administered to anyone over the age of 6 months that does not have insurance or is underinsured. The flu vaccine will be available for anyone over the age of 6 months. There is no cost to receive the flu or COVID-19 vaccines, please bring health insurance card.

For more information, please contact the Jefferson Parish Emergency Management Department at (504) 349-5360.

See the original post here:

Flu and Covid-19 Vaccine drive happening in Jefferson Parish - WDSU New Orleans

COVID and flu vaccine guidance from the Center on Healthy Aging – YourCentralValley.com

November 3, 2023

COVID still remains a public health priority, especially among the older population where the disease has been more serious.

Kathleen Cameron, senior director of The National Council on Agings Center for Healthy Aging, joined the show with COVID and flu vaccine guidance for older adults.

Read the original:

COVID and flu vaccine guidance from the Center on Healthy Aging - YourCentralValley.com

Why Some Vaccines Prevent Disease While Others Lower Severity – Northeastern University

November 3, 2023

When the first vaccines for COVID-19 rolled out in December 2020, some people hoped they would be a silver bullet against the novel virus the way that polio and smallpox shots are nearly 100% effective against those diseases.

Instead, the updated COVID vaccine is being compared to the flu vaccine in the sense that its goal is to prevent severe disease, hospitalization and death rather than to eliminate infection entirely.

That doesnt mean the COVID and flu vaccines are failures, health experts at Northeastern say.

Mansoor Amiji, university distinguished professor of pharmaceutical sciences and chemical engineering, and Neil Maniar, professor of the practice in public health, say vaccines differ according to whether the viruses theyve been designed to quell are mutating or stable.

The measles and polio viruses are stable and dont mutate over time, Amiji says. The same is true for the virus for smallpox, which has been eradicated globally and only exists in the lab.

Making a vaccine with an antigen from a stable virus means a vaccinated persons immune system is primed to recognize and destroy the virus every time it appears, Amiji says.

If you start to see an outbreak of polio, in any part of the world, these vaccines are still incredibly effective. If the virus crops up, it wont evade the immune system or evade the vaccines response, he says.

Such is not the case with influenza, the virus that causes flu, and SARS-CoV-2, the virus that causes COVID-19.

COVID-19 has gone through an alphabet soup of strains, from the Alpha to Beta, Delta, Omicron, Pirola and Eris and is still evolving.

Even though we have so many people either having natural infection or who have been vaccinated, these viruses continue to mutate, Amiji says.

Were making vaccines that are looking for the spike proteins in the virus and are basically teaching our immune cells to look for the spike protein. But if the spike protein is mutating, then the vaccine efficacy starts to wane, he says.

Influenza mutates even faster, which is why there are new flu vaccine formulas every year and why 50% is considered a good efficacy rate, he says.

The combinations of antigenic proteins on the influenza surface, known as hemagglutinin and neuraminidase the H and N in virus nomenclature vary year to year and even within the flu season, Amiji says.

The flu vaccine is made up of a cocktail of these peptides, he says. Its really a guessing game. There is no way of knowing which strain will be prevalent and which vaccines will work, he says.

That rate is making the flu vaccine a harder sell among the public.

The Centers for Disease Control and Prevention says during a year with a good match, vaccination reduces the risk of flu illness by between 40% and 60% among the overall population.

Consumer research shows that many people believe flu vaccination doesnt work because of first- or second-hand experience where vaccination may not have prevented illness, the CDC says.

Concerned about drops in flu vaccination among high-risk groups such as pregnant women and children during the COVID-19 pandemic, the CDC this fall came up with a new campaign one that spotlights how the flu vaccine can reduce not only the risk of influenza but of potentially serious outcomes.

Called Wild to Mild, the campaign pairs images of powerful and dangerous animals with innocuous counterparts a raging bear with a teddy bear or a lion with a kitten, for instance.

Its definitely a change in messaging, Maniar says.

Its a clarification in what is being messaged, he says. There has been sort of this prevailing idea that, If I get the vaccine, Im not going to get the flu. And we know thats not the case.

Theres a lot of empirical evidence to show what the vaccine really does is it reduces severity. It reduces the likelihood that someone is going to be hospitalized or even die from getting the flu, Maniar says.

The same is true with vaccination for COVID-19, he says.

There are some individuals who after getting vaccinated will not get the flu or get COVID, because their immune systems have a more robust protection against the virus, Maniar says.

But thats not the case for everyone. I think thats where managing expectations comes into play, he says.

The updated COVID vaccine no longer called a booster by the FDA targets the XBB.1.5 Omicron strain prevalent this spring. Pfizer says the monovalent vaccine also addresses currently circulating offshoots of Omicron, known as Eris or EG.5, and Pirola, BA.2.86.

Vaccination remains right now our best strategy to not just ideally prevent but to have a benign type of infection, just basically a few chills and a sore throat, Amiji says.

It would be great if you dont get infected. But even if you do get the infection it will be very mild, and you wont be hospitalized.

The flu virus undergoes both antigenic shifts and drifts, Amiji says.

The former is when hemagglutinin and neuraminidase undergo such huge changes the influenza vaccine is not effective at all. Drift is when slight modification occurs, he says.

There are glimmers of hope that both flu and COVID vaccines will become more effective in the future, Amiji says.

Using AI in pharmaceutical technology has led to preclinical studies showing the effectiveness of a universal mRNA flu vaccine that covers more than dozen flu strains in a season, he says.

The same concept is being applied to a universal COVID vaccine, Amiji says.

Theyre not in the clinic yet, he says, but adds he wouldnt be surprised if they were on the market by next fall.

In the meantime, Amiji says he plans to get the updated COVID vaccine and a flu shot this weekend.

I would absolutely recommend that people get their flu and COVID vaccines as soon as possible, he says.

As we get toward the winter season, and people start congregating with Thanksgiving holidays and Christmas holidays, the propensity for infection just increases.

Cynthia McCormick Hibbert is a Northeastern Global News reporter. Email her at c.hibbert@northeastern.edu or contact her on X/Twitter @HibbertCynthia.

Originally posted here:

Why Some Vaccines Prevent Disease While Others Lower Severity - Northeastern University

Predictions are in: How bad will this flu season be? – The Daily Briefing

November 3, 2023

What experts expect this flu season

In the Southern Hemisphere, influenza cases picked up a bit earlier than they typically do in some countries, but ultimately didn't result in an especially large number of hospitalizations or deaths, experts said.

Experts also said this year's flu vaccine is a good match to the predominant strain of influenza.

One study found the current flu vaccine reduced the risk for flu-related hospitalizations by 52% in the Southern Hemisphere, which is a strong indicator of how effective the vaccine is, according to Alicia Budd, head of CDC's domestic influenza surveillance team.

Rick Zimmerman, a professor of family medicine and flu epidemiology at the University of Pittsburgh, cautioned that while epidemiologists tend to look at the Southern Hemisphere to predict this year's flu season, the United States doesn't always follow the same patterns.

"Sometimes you get a new variant that arises that they did not experience in the Southern Hemisphere," he said. And other times, the main influenza strain circulating in the Southern Hemisphere varies, making it difficult to predict what the U.S. flu season will look like.

Seema Lakdawala, an associate professor of microbiology and immunology at Emory School of Medicine, said flu cases will likely start rising soon now that COVID-19 cases are starting to drop.

Peaks of different types of viruses don't often overlap, Lakdawala said. Once you recover from one respiratory virus, it's unlikely you'll be infected with another one for around a month or two, as your innate immune response increases your protection from another infection.

CDC recommends that everyone ages six months and older get vaccinated for the flu. Ideally, those eligible for the flu vaccine got their shot by the end of October. However, it's still good to get vaccinated as long as influenza is circulating, which can stretch into the spring.

Once you get your shot, it'll take your body around a week or two to develop enough antibodies to protect you, Zimmerman said. Your antibody levels will peak around three to four weeks after you receive the vaccine and then will start to decline, but experts say you're still protected for around four to six months.

Shortly after you're vaccinated, your antibody levels are high enough that you could be protected from a nose infection as well as a chest or lung infection. Months later, when those antibody levels begin to decline, you won't be as protected above the throat but should still be protected in your chest.

"So you likely have protection for your lungs, which will keep you out of the hospital and keep you from getting really sick," Zimmerman said. "The vaccine may not prevent nose colds but it prevents a lot of hospitalizations and deaths due to heart and lung issues."

If you do get sick, especially if you're more at-risk for serious complications, you should see a doctor to determine whether you have the flu or COVID-19. Doing so early can help you get started on antiviral medication, which can help reduce the length and severity of your illness.

"The sooner you take it, the more effective it will be," Budd said. (Reddy, Wall Street Journal, 10/30)

View original post here:

Predictions are in: How bad will this flu season be? - The Daily Briefing

Page 38«..1020..37383940..5060..»